Subscribe To
Gilead's (gild) veklury gets fda nod for label expansion
Gilead's (GILD) antiviral treatment Veklury (remdesivir) has now been approved for the treatment of COVID-19 patients with severe ...
July 17, 2023, 12:47 pm
renalytix: commercializing first ai kidney disease diagnostic tool
renalytix's lead product, KidneyIntelX, an AI diagnostic tool for kidney disease, has received FDA appr...
July 16, 2023, 2:49 am
Gilead sciences says fda has approved veklury in covid patients with severe kidney disease
Gilead Sciences Inc. GILD, +0.43% said Friday the U.S. Food and Drug Administration has approved the use of its Veklury, or remdesivir, for patients w...
July 14, 2023, 8:12 am
Why is cadrenal therapeutics (cvkd) stock up 71% today?
Cadrenal Therapeutics (NASDAQ: CVKD ) stock is taking off on Wednesday despite a lack of news from the...
July 12, 2023, 8:48 am
China stocks lose ground against japanese rivals
China Stocks Lose Ground Against Japanese Rivals In the thrilling world of investing, some stocks are like wild rollercoasters, offering incredible hi...
July 4, 2023, 2:25 pm
Vera: new kidney data, may be a potential next big pharma m&a target
Vera Therapeutics revealed 36-week efficacy and safety findings of its Phase IIb ORIGIN clinical study of atacicept for IgAN at the 60th European
July 4, 2023, 9:42 am
Why is renalytix (rnlx) stock up 45% today?
renalytix (NASDAQ: RNLX ) stock is rising higher on Friday after the medical company got marketing perm...
June 30, 2023, 8:13 am
Instil bio announces oral presentation of itil-306 preclinical data at british society for gene and cell therapy annual conference
Presented data showing that folate receptor α (FRα)-CoStAR enhanced activity of TILs against autologous NSCLC, ovarian, and ...
June 26, 2023, 8:38 pm
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Chinook therapeutics presents data from chk-336 phase 1 trial in healthy volunteers and new insights into the role of failed repair in chronic kidney disease at the 60th european renal association (er
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Phar...
June 17, 2023, 11:15 am
Anemia, chronic renal disease and chronic heart failure: the cardiorenal anemia syndrome
The mortality and morbidity of congestive heart failure (CHF) have improved slightly over the years but are still very high. Many patients with CHF ar...
June 15, 2023, 1:46 pm
Chinook therapeutics to present updated data from zigakibart (bion-1301) phase 1/2 trial in patients with iga nephropathy (igan) at the 60th european renal association (era) congress
SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developmen...
June 12, 2023, 4:00 pm
Novartis (nvs) to buy chinook for $3.5b to strengthen pipeline
Novartis (NVS) is looking to strengthen its renal pipeline with the acquisition of Chinook Therapeutics...
June 12, 2023, 1:43 pm
European patent office to grant zyversa therapeutics’ patent application for cholesterol transport mediator™ var 200 for use in patients with diabetic nephropathy/diabetic kidney disease
Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accum...
June 6, 2023, 1:07 pm
Spexis provides business update and announces financial results for the full year 2022
Ad hoc announcement pursuant to Art. 53 LR USD 4.5 million capital commitment from SPRIM Global Investments to enable initiation of ColiFin® COPILOT ...
May 30, 2023, 5:15 am
Gilead's (gild) veklury gets positive chmp view for extended use
Gilead (GILD) obtains positive opinion for the use of Veklury in COVID-19 patients with severe renal im...
May 26, 2023, 11:35 am